Clinical Trials
Clinical Trials More...
Health Care Professionals
How using BronkoTest can reduce emergency exacerbations, saving money and improving… More...


1. Seemungal TA, Donaldson GC, Paul EA, et al. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease.  Am J Respir Crit Care Med. 1998 157:1418-22
2. Donaldson GC, Seemungal TA, Bhowmik A, et al.  Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002 57: 847-52.
3. Dowson LJ, Guest PJ, Stockley RA.  Longitudinal changes in physiological, radiological and health status measurements in alpha(1)-antitrypsin deficiency and factors associated with decline.  Am J Respir Crit Care Med. 2001 164: 1805-9.
4. Stockley RA, O’Brien C, Pye A, Hill SL.  Relationship of sputum color to nature and outpatient management of actue exacerbations of COPD.  Chest. 2000 117: 1638-45.
5. Janoff A, Sloan B, Weinbaum G, et al.  Experimental emphysema induced with purified human neutrophil elastase: tissue localisation of the instilled protease.  Am Rev Respir Dis.  1977 115: 461-78.
6. Lucey EC, Stone PJ, Breuer R, et al.  Effect of combined human neutrophil cathepsin G and elastase on induction of secretory cell metaplasia and emphysema in hamsters, with in vitro observations on elastolysis by these enzymes.  Am Rev Respir Dis. 1985 132: 362-6.
7. Sommerhoff CP, Nadel JA, Basbaum CB, Caughey GH, Neutrophil elastase and cathepsin G stimulate secretion from cultured bovine airway gland serous cells.  J Clin Invest. 1990 85: 682-9.
8. Smallman LA, Hill SL, Stockley RA.  Reduction of ciliary beat frequency in vitro by sputum from patients with bronchiectasis: a serine proteinase effect.  Thorax. 1984 39: 663-7.
9. White AJ, Gompertz S, Bayley DL, et al.  Resolution of bronchial inflammation is related to bacterial eradication following treatment of exacerbations of chronic bronchitis.  Thorax. 2003 58: 680-5.
10. Gompertz S, O’Brien C, Bayley DL, et al.  Changes in bronchial inflammation during acute exacerbations of chronic bronchitis.  Eur Respir J.  2001 17: 1112-9.
11. Crooks SW, Bayley DL, Hill SL, et al.  Bronchial inflammation in acute bacterial exacerbations of chronic bronchitis:  the role of leukotriene B4.  Eur Respir J 2000 15: 274-80.
12. Hill AT, Campbell EJ, Hill SL, et al.  Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis.  Am J Med.  2000 109: 288-95.
13. Anthonisen NR, Manfreda J, Warren CP, et al.  Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease.  Ann Intern Med.  1987 106: 196-204.
14. Rodriguez-Roisin R.  Toward a consensus definition for COPD exacerbations.  Chest.  2000 117(5 Supple 2): 398S-401S.
15. Stockley RA, Bayley D, Hill SL, et al.  Assessment of airway neutrophils by sputum colour: correlation with airways inflammation.  Thorax.  2001 56: 366-72.
16. Woolhouse IS, Hill SL, Stockley RA.  Symptom resolution assessed using a patient directed diary card during treatment of acute exacerbations of chronic bronchitis.  Thorax. 2001 56: 947-53.
17.  Sapey E, Bayley D, Ahmed A, Newbold P, Snell N, Stockley RA.  Inter-relationships between inflammatory markers in stable COPD patients with bronchitis: the intra and inter patient variability.  Thorax, 63: 493-499.
18.  Gompertz S, Bayley DL, Hill SL, Stockley RA.  Relationship between airway inflammation and frequency of exacerbations in patients with smoking related COPD.  Thorax; 56: 36-41.

Copyright/Disclaimer | BronkoTest Ltd 2008 | Design by JNZ